Dr Joe Nichols (University of Leeds) presented a methodology for assessing the information requirements of clinicians. This is part of the European Community AIM project. They study the information needs of clinicians by careful observation. A prototype computer system is then installed, giving clinicians an idea of what is possible. Refinement is based on user feedback. This co-operative user-centred approach avoids the problem of a 'top-down' methodology, where the system is simply imposed, and 'bottom-up' development, with duplication of effort and development of divergent, incompatible systems.
The ultimate technophobic nightmare might be the computer as brain surgeon. Dr Stephen Hughes (St Thomas' Hospital) showed that we are already some way along this road. The massive power of the Stardent Titan Graphics Supercomputer is harnessed to a CT scanner to calculate the co-ordinates for stereotactic implantation of radioactive iodine to treat brain tumours. At present, a neurosurgeon is still required to drill the burr holes!
Medical research
Dr Sandra Chittenden (Middlesex Hospital) demonstrated the use of a portable microcomputer to investigate microcirculatory control in diabetic neuropathy. A novel test has been developed using the computer to control rapidly varying temperature stimuli to the finger, and to analyse the results of a laser doppler probe measuring blood flow in the pulp. Local blood flow was less responsive to thermal stimuli in diabetics than in controls.
Mr M Porteous (Orthopaedic Senior Registrar from Margate) gave a well illustrated account of the use of a personal computer to produce transparencies at low cost. Using a standard 35 mm SLR camera to photograph a computer screen, good quality slides can be produced for around 20 pence each. It is best to use a long lens (l00 mm or greater) to reduce the effect Journal of the Royal Society of Medicine Volume 84 September 1991 567 of curvature of the screen, a long exposure time (0.5 s or more) and -in the case of most text slides on a dark background -to underexpose the film by one or two stops.
Image analysis Dr D Cornick (University College of Medicine Dental
School) demonstrated a system for digital storage and analysis of dental radiographs. The X-ray is digitized from a video camera onto an optical disk which can hold several thousand images. The software, which runs under Microsoft Windows, allows qualitative and quantitative changes in bone to be monitored. This system has potential application in several other areas including orthopaedics and the assessment of osteoporosis.
Practice administration
Mr D Boyle and Dr N Carter (Medical Computing Unit, Ninewells Hospital, Dundee) presented their general practice system and its underlying development philosophy. The main requirements of any GP system are ease of use, quality of data stored, fulfilment of new contract requirements, speed and flexibility, ie the ability to adapt to local requirements and to evolve. Flexibility was identified as the key shortcoming of most current commercial off-the-shelf systems. Their database is flexible, portable across different hardware and software platforms, and capable of being customized to suit any individual practice.
The next meeting of the Forum is on Tuesday 17 September 1991 at the Royal Society of Medicine, London. The theme topic will be Integrated Systems. A further meeting will be held in Middlesbrough in Spring 1992.
J W Fairley

Computers in Medicine Forum Committee
Medicalizing the menopause: hormone replacement therapysolution or problem?
Keywords: hormone replacement therapy; oestrogen; breast cancer; osteoporosis This attention-provoking topic resulted in a more narrowly 'medicalized' evening than some of the audience might have hoped. Despite the efforts of at least one questioner from the floor to open the discussion out to broader psycho-social issues, the three platform speakers stuck determinedly to their technical lathes, producing a welter of statistics which -though valid and important -did rather reduce the whole issue to a dialogue about the respective demerits of osteoporosis versus breast cancer.
Ms Linda Cardozo (Consultant Obstetrician & Gynaecologist, Kings College Hospital, London) was broadly in favour of HRT (hormone replacement therapy), feeling that for many women its advantages would outweigh its possible drawbacks. She identified the menopause, now occurring in western European women at an average age of 51 years as diagnosed by the last monthly period, as one of five basic stages in female existence, but said that since 'menopausal symptoms' may appear five or more years before this moment is reached the term 'climacteric' to cover the whole phase may be more suitable. As symptoms of the climacteric, she listed (1) vasomotor dysfunction (hot flushes, night sweats) -an immediate manifestation of oestrogen withdrawal; (2) psycho-social troubles such as mood changes, insomnia, loss of memory etc. which are hard to categorize as being directly or necessarily due to hormonal changes;
(3) urogenital dysfunction, vaginal dryness etc, which typically set in only a few years after the menopause; (4) osteoporosis which may occur later again, and (5) cardiovascular disease, of which the same is true.
Oestrogen is usually successful in the symptomatic relief of 1, 2 and 3. It also reduces osteoporosis and Report of meeting of Open Section, 15 April 1991 0141-0768/91/ 090567-03/$02.0010 © 1991 The Royal Society of Medicine the death rate from cardiovascular disease. Its disadvantage is that it can affect the most sensitive tissue in the body, including the breast. It is not contra-indicated in cases of benign breast disease, and its short-term use does not matter, but with long-term use (10-20 years) there appears to be an increased risk of breast cancer. This risk is reduced again if a combination HRT dose of oestrogen plus progestogen is given, but in 10% of women progestogen causes either PMT or migraine. Progestogen also offers protection against endometrial cancer, but this is irrelevant in women who have already had a hysterectomy -a group for which HRT is commonly prescribed.
HRT may be absorbed orally, vaginally or by implants and patches. Different methods may be suitable according to the problems the therapy is particularly intended to relieve. As to who 'needs' HRT, Ms Cardozo listed women who undergo a premature menopause, those who have had a bilateral oophorectomy, those with unpleasant climacteric symptoms as above, those with a family history of osteoporosis and finally -and more controversiallythose who ask for it. She said that a course of 2-3 years is usually enough for symptom-relief, but if the therapy is intended as a protection against osteoporosis then it must be continued for 10 years or longer. Women on HRT should be regularly monitored for blood pressure, cervical and breast cancer etc. but (contrary to a common myth) HRT does not in itself lead to either an increase in blood pressure or to weight gain. Nor is it contra-indicated for epileptics, diabetics and smokers. It does not have any contraceptive effect. Contra-indications are a history of breast or endometrial cancer -and some women find HRT 'unacceptable' because it is accompanied by regular withdrawal-bleeding like a scant monthly period continuing. Ms Cardozo was too polite to add that some women will complain about anything. She concluded her talk by saying that women who request HRT when they have no particular symptoms in need of relief should be presented with the facts and left to make up their own minds.
The next speaker, Dr Ignac Fogelman (a consultant physician of Guy's Hospital, London) addressed himself entirely to the subject of osteoporosis -a very common disease which, he said, usually only becomes apparent after an individual has sustained a fracture. Fractures of the hip or wrist are the most obvious, the former requiring hospitalization, but in fact the risk of these fractures over a female lifetime is only 15% whereas the risk of a spinal fracture -the collapse of one or more vertebrae leading classically to 'dowager's hump' which may not be diagnosed at the time -is 35%. Everyone loses some bone-mass after the age of about forty, but men only do so slowly whereas the process is accelerated in women by the oestrogen withdrawal of the menopause. The hypothetical fracture-threshold is therefore reached much earlier in women, but there is a wide range within the normal. Dr Fogelman instanced the case of one woman who had lost 8~inches stature through vertebrae collapse by the age of only 59 years: she had had her menopause at 40 years and had had no HRT. Hip fractures among the elderly cost the Health Service a great deal of money, and HRT can prevent further bone-loss at any age; it is never 'too late' to prescribe it. However, Dr Fogelman added, our concern should also be to stop old ladies falling over or to mitigate the consequences: he ventured to suggest that in some cases HRT might be less useful than padded knickers! He outlined various techniques for measuring bone density, and said that he regarded this as providing a better indicator of who should be treated than the attempt to estimate 'risk factors': so many of the latter are crude statistics relating to fair hair, smoking, drinking, family history etc. Guy's has a screening programme. Wide individual variety around the mean loss of bone mass can be due not only to present loss-rate but to the woman's hormonal history: Dr Fogelman mentioned a case known to him in which the woman, 'a health fanatic' taking a regular calcium supplement, nevertheless had very poor bone density for her age; it transpired she had no periods for ten years as a young woman and then had had her menopause at 40, thus she had had a great loss of exposure to oestrogen. He added, however, that, like the previous speaker, he thought that women, properly advised, should make up their minds on HRT for themselves.
Professor Klim McPherson (London School of
Hygiene) did not dissent from this, but added the modification that women should be 'as well-informed as they want to be'. His disagreement with the other speakers was that, in his view, the evidence on the long-term risks ofHRT is more disturbing than they suggested. Long-term studies, he said, are not easy to carry out and their assessment is problematical. Not enough women have taken part in such studies and in addition the composition ofHRT has changed over the course of time. Also, a new generation of women will soon be coming up to the menopause who have been taking an oestrogen-based contraceptive pill from their early adulthood, which today's middleaged to elderly women have not.
The breast cancer risk may be doubled by long-term HRT. This may not sound much but by the age of 75 the risk without extra oestrogen is already 5.9% of women: do we really want to double that to close on 12% merely to avoid the non-fatal risk of osteoporosis? -breast cancer already kills between 12 000 and 13000 women in this country every year. To put this in perspective, it is true that a late natural menopause also increases the risk of breast cancer, but with HRT the risk increases the longer the treatment is pursued, ie 8-10 years use of HRT already increases the risk by 50%. This, said Professor McPherson, is the kind of figure we need to set against undoubted symptomatic and other benefits ofHRT in making our decision.
Question-time threw up few entirely new points, mainly confirming the overall impression that there is a lack of really adequate, long-term data on which to base definitive advice. A gynaecologist remarked that it is all very well for an epidemiologist to say 'we aren't sure' but in clinical practice you have to make up your mind. There was criticism of certain private health groups which push HRT very hard as being without ill-effects. A questioner asked about the relative cost of the community of HRT as opposed to treatment for osteoporosis-fractures, but it was explained that this cannot be quantified as there is no method for measuring present costs against future hypothetical ones. One questioner remarked that the discussion seemed rather to be ignoring the fact that we all have to die of something, so is it not really just a question of whether we prefer to die of cancer or cardiovascular disease rather than of 'risk'? The answer to this was 'It's not a choice of disease, it's a choice of age of dying.' The suggestion (also made earlier by Jean Gaffin, who chaired the meeting) that we hear too much about 'the menopausal woman' as needing HRT to 'cure' her, was on the whole rejected by the speakers: Ms Cardozo said that she saw many more women who had been refused HRT by their family doctors than women who had been prescribed it apparently unnecessarily or undesirably. It was also agreed it was a pity that, in the present political and economic climate, money was not likely to be made
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Treatment of colonic anastomotic strictures with 'through the scope' balloon dilators
Dinnen and Motson (May 1991 JRSM, p 264) claim without any justification that balloon dilatation with 'through the scope' dilators performed without fluoroscopic guidance, is a simpler technique than radiologically guided dilatation performed without endoscopy.
Previous studies have shown that radiologically guided balloon dilatation is a simple and effective procedurev'. One major advantage of radiologically guided dilatation is that fluoroscopy can be used to assess the contour of the balloon during inflation and allows the operator to see clearly how well the 'waisting' of the balloon disappears as successful dilatation occurs', The use of guide wires and contrast under fluoroscopic control may allow the operator to negotiate tight complex strictures.
The aim of balloon dilatation is to avoid the need for further surgery and we believe that the chances of this can be further improved by close cooperation between endoscopist and radiologist. available for GPs to have access to scanning machines to gauge their patients' bone-density and so come to informed decisions.
Possibly the most significant point to emerge from the question-period was the fact -hitherto apparently unknown even to several professionally concerned members of the audience -that only between 7% and 8% of post-menopausal women in the UK are on HRT and many of these take it only for a brief period. The percentage is much greater in the USA and it is therefore on American research that most of the figures depend.
Gillian Tindall
The authors reply below:
We find ourselves in agreement with most of their points. We do not dispute that radiologically-guided balloon dilatation is a simple and effective procedure. Likewise we agree that the aim of balloon dilatation is to avoid the need for major surgery and that close cooperation between radiologist and endoscopist can only further this objective. However, we stand by our belief that 'through the scope' balloon dilatation is a simpler technique than radiologically-guided dilatation performed without endoscopy. The placement of the guide wire through a stricture under direct vision at the time of endoscopy is often technically easier than under fluoroscopic control and exposes neither the patient nor the doctor to X-radiation. Whilst one cannot see the disappearance of the waisting of the balloon after successful dilatation, one can obtain even better evidence of success by direct inspection of the stricture site postdilatation and passage of the colonoscope through the stricture.
R W MOTSON
Colchester General Hospital M D DINNEEN
Turner Road, Colchester C04 5JL
Surgical roots and branches
My attention has been drawn to your kind review of my Surgical Roots and Branches (March 1991 JRSM, p 186). However, the first paragraph of that review is strangely at variance with the facts recorded in the book. 'Only in retirement did the author have time to read newspapers, journals, history, biography and economics' writes L'Etang. On the contrary, it was in my student days that I found little time for such reading. The book records that, shortly after qualifying and spending 6th years in the RAMC, I invariably had a mini-library with me; that, and the carrying of an umbrella (but not on the battlefield!) are the only two characteristics which I recorded as sharing with the first Duke of Wellington. After the war I regularly took two daily newspapers, the British Medical Journal, The Lancet and other journals, and had many letters published in the medical and daily press. The reading of history, biography and economics, though mainly holiday activities, were very much an important part of my early post-war life,
